Monovisc 88 MG/4 ML syringe 4ML
Ended Awarded
- Contract number
- SPE2DR26FA33B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,380
Award facts
- Contract value 100% obligated
- $11,379.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on July 13, 2026, for MONOVISC 88 MG/4 ML syringes with a ceiling value of $11,379.65. Place of performance is Conshohocken, PA. The order carries firm fixed-price pricing and ultimate completion is July 14, 2026.
Quick answers
Who was awarded contract SPE2DR26FA33B?
SPE2DR26FA33B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 13, 2026.
How much is contract SPE2DR26FA33B worth?
The government has obligated $11,380 on SPE2DR26FA33B.
Is contract SPE2DR26FA33B an order under another contract?
Yes. SPE2DR26FA33B is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FA33B competed?
The extent of competition for SPE2DR26FA33B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award